AGP Picks
View all

The Boston Examiner: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Boston Examiner.

Press releases published on November 12, 2026

Hill Research CEO Dr. Louise Liu Named Among Greater Boston’s 2026 Ten Outstanding Young Leaders
Net Tel One Announces Publication of AI Unmasked: From Big Scary Monster to Trusted Partner, by Partner/CTO Greg O’Neill
Creatio Winter 2027 Release Event to Showcase What’s Next for AI, CRM and Industry Workflows
The Kendall-Crossing Blueprint: Why Biotech and Life Science Road Warriors are Landing on O'Brien Highway
Dutch Academic addresses the Growing Problem of Fake References in Research
Donoghue Forlines Marks One-Year Anniversary of DF Tactical 30 ETF
STR Awarded U.S. Space Force Agreement to Advance Space-Based Air Moving Target Indicator Capabilities
Bioqore Advances Biomanufacturing in Drug Development with Predictive AI & Appoints Janette Phi to Lead Business Growth
Kortney Forsblom, Profiled by Influential Women, Leads With Compassion and High Standards in Hospitality
The Engine Opens Second Ignition Pass Call for Applications, with Shell Returning as Enterprise Partner
As Customers Redefine Premium Value, OM Strategic Forecasting Puts a Price on Delaying an AI-Native Business Model Shift
Veridas Successfully Integrates its Identity Verification Solutions with Epic to Secure Digital Healthcare Access
LEQEMBI® Pen (Subcutaneous Formulation of LEQEMBI®) Now Available in Japan for Patients with Early Alzheimer’s Disease
Creatio Releases UK Edition of The State of Enterprise AI Adoption Report
New Drug Application Submission Completed for Zipalertinib Plus Chemotherapy in First-Line EGFR Exon 20 Insertion Mutation Non-Small Cell Lung Cancer
Praxis Precision Medicines Details Launch Readiness for Relutrigine and Ulixacaltamide and Outlines Expanded Pipeline in Preparation to be the Preeminent CNS Biotech at Investor Day
Prime Medicine Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
Crescent Biopharma Reports Third Quarter 2026 Financial Results and Recent Business Highlights
Spero Therapeutics Announces Third Quarter 2026 Operating Results and Provides Business Update
Candel Therapeutics Reports Third Quarter 2026 Financial Results and Recent Corporate Highlights

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

The Boston Examiner

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.